253 related articles for article (PubMed ID: 28848438)
21. Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.
Fujiwara R; Yokoi T; Nakajima M
Front Pharmacol; 2016; 7():388. PubMed ID: 27822186
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
23. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
[TBL] [Abstract][Full Text] [Related]
24. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
25. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer.
Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS
Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807
[TBL] [Abstract][Full Text] [Related]
26. Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes.
Kong TY; Kim JH; Kim DK; Lee HS
Arch Pharm Res; 2018 Jul; 41(7):691-710. PubMed ID: 30039377
[TBL] [Abstract][Full Text] [Related]
27. The role of drug metabolizing enzymes in clearance.
Di L
Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):379-93. PubMed ID: 24392841
[TBL] [Abstract][Full Text] [Related]
28. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
29. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice.
Chen J; Zheng H; Zeng S; Xie C; Li X; Yan T; Gong X; Lu L; Qi X; Wang Y; Hu M; Zhu L; Liu Z
Mol Pharm; 2017 Sep; 14(9):2967-2976. PubMed ID: 28661152
[TBL] [Abstract][Full Text] [Related]
30. Modulation of metabolizing enzymes by bisphenol a in human and animal models.
Quesnot N; Bucher S; Fromenty B; Robin MA
Chem Res Toxicol; 2014 Sep; 27(9):1463-73. PubMed ID: 25142872
[TBL] [Abstract][Full Text] [Related]
31. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory and Inductive Effects of
Jeong H; Kim S; Kim MY; Lee J; An BH; Kim HD; Jeong H; Song YS; Chang M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380747
[No Abstract] [Full Text] [Related]
33. Differential stability of drug-metabolizing enzyme activities in primary rat hepatocytes, cultured in the absence or presence of dexamethasone.
McMillan JM; Shaddock JG; Casciano DA; Arlotto MP; Leakey JE
Mutat Res; 1991 Jul; 249(1):81-92. PubMed ID: 2067545
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
Niwa T; Murayama N; Yamazaki H
Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
[TBL] [Abstract][Full Text] [Related]
35. An update on the role of intestinal cytochrome P450 enzymes in drug disposition.
Xie F; Ding X; Zhang QY
Acta Pharm Sin B; 2016 Sep; 6(5):374-383. PubMed ID: 27709006
[TBL] [Abstract][Full Text] [Related]
36. An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides.
Kazmi F; Yerino P; McCoy C; Parkinson A; Buckley DB; Ogilvie BW
Drug Metab Dispos; 2018 Aug; 46(8):1066-1074. PubMed ID: 29735754
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues.
Schwartzman ML; Masferrer J; Dunn MW; McGiff JC; Abraham NG
Curr Eye Res; 1987 Apr; 6(4):623-30. PubMed ID: 3107908
[TBL] [Abstract][Full Text] [Related]
38. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.
Schaefer O; Ohtsuki S; Kawakami H; Inoue T; Liehner S; Saito A; Sakamoto A; Ishiguro N; Matsumaru T; Terasaki T; Ebner T
Drug Metab Dispos; 2012 Jan; 40(1):93-103. PubMed ID: 21979928
[TBL] [Abstract][Full Text] [Related]
39. Effect of eugenol on drug-metabolizing enzymes of carbon tetrachloride-intoxicated rat liver.
Kumaravelu P; Dakshinamoorthy DP; Subramaniam S; Devaraj H; Devaraj NS
Biochem Pharmacol; 1995 May; 49(11):1703-7. PubMed ID: 7786311
[TBL] [Abstract][Full Text] [Related]
40. Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles.
Bacqueville D; Jacques C; Duprat L; Jamin EL; Guiraud B; Perdu E; Bessou-Touya S; Zalko D; Duplan H
Toxicol Appl Pharmacol; 2017 Aug; 329():190-201. PubMed ID: 28601433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
